Evaluation of p57 expression in early disordered pregnancies with molar status vs non- molar ones
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
293 16
Ultima descărcare din IBN:
2024-03-28 14:45
Căutarea după subiecte
similare conform CZU
618.32+611.013 (2)
Științe medicale. Medicină (11143)
Anatomie. Anatomie umană și comparată. (237)
SM ISO690:2012
DAVID, Valeriu, PETROVICH, Virgil, ŞAPTEFRAŢI, Lilian, FULGA, Veaceslav, CARPENCO, Ecaterina, FRANȚ, Elena. Evaluation of p57 expression in early disordered pregnancies with molar status vs non- molar ones. In: Moldovan Medical Journal, 2022, nr. 2(65), pp. 5-12. ISSN 2537-6373. DOI: https://doi.org/10.52418/moldovan-med-j.65-2.22.01
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Moldovan Medical Journal
Numărul 2(65) / 2022 / ISSN 2537-6373 /ISSNe 2537-6381

Evaluation of p57 expression in early disordered pregnancies with molar status vs non- molar ones

DOI:https://doi.org/10.52418/moldovan-med-j.65-2.22.01
CZU: 618.32+611.013

Pag. 5-12

David Valeriu12, Petrovich Virgil21, Şaptefraţi Lilian1, Fulga Veaceslav1, Carpenco Ecaterina1, Franț Elena1
 
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
2 Institute of Mother and Child
 
Proiecte:
 
Disponibil în IBN: 30 ianuarie 2023


Rezumat

Background: The molar and non-molar lesions are determined during histomorphological examination and treated as inconclusive. The establishing of a marker by immunohistochemical investigations could influence the accuracy of the morphopathological diagnosis. The aim is evaluation of p57 immunoexpression in the trophoblastic germ compartment in molar and non-molar pregnancies. Material and methods: Abortion products from 15 patients with hydatidiform mole, 18 pregnancies solved on social indications and 16 short-term disordered pregnancies were evaluated depending on the immunoexpresion of p57. Results: The hydatidiform mole was classified based on anti-p57 immunoexpression into: complete hydatidiform mole – 8 cases (negative immunoexpression or expression in ˂10% of villous cytotrophoblast) and partial hydatidiform mole – 7 cases (positive expression in ˃10% of the villous cytotrophoblast). Basal deciduous and extravillous cytotrophoblasts were positive in 100% of cases and served as internal control. Hepatocytes were used as negative control. In the control group, the positive immunoexpression was attested in >10% of cases in the villous trophoblast. Conclusions: Differential immunoexpression of p57 protein in the germinal cytotrophoblast allows subclassification of molar pathology into complete and partial forms, while not allowing the differentiation between partial hydatidiform mole and non-molar lesions. Immunohistochemical evaluation of p57kip2 protein in molar and non-molar pathology is useful in differential diagnosis as a complementary method.

Cuvinte-cheie
anti-p57, fetal concept, hydatidiform mole, trophoblastic disease